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Abstract
Background: The NMDA receptor represents a particularly important site of ethanol action in the CNS. We recently reported
that NMDA receptor 2B (NR2B) gene expression was persistently up-regulated following chronic intermittent ethanol (CIE)
treatment. Increasing evidence that epigenetic mechanisms are involved in dynamic and long-lasting regulation of gene
expression in multiple neuroadaptive processes prompted us to investigate the role of DNA methylation in mediating CIE-
induced up-regulation of NR2B gene transcription. To dissect the changes of DNA methylation in the NR2B gene, we have
screened a large number of CpG sites within its 59-regulatory area following CIE treatment.
Methods: Primary cortical cultured neurons were subjected to ethanol treatment in a CIE paradigm. Bisulfite conversion
followed by pyrosequencing was used for quantitative measurement and analysis of CpG methylation status within the 59-
regulatory area of the NR2B gene; chromatin immunoprecipitation (ChIP) assay was used to examine DNA levels associated
with methylation and transcription factor binding. Electrophoretic mobility shift assay (EMSA) and in vitro DNA methylation
assays were performed to determine the direct impact of DNA methylation on the interaction between DNA and
transcription factor and promoter activity.
Results: Analysis of individual CpG methylation sites within the NR2B 59regulatory area revealed three regions with clusters
of site-specific CpG demethylation following CIE treatment and withdrawal. This was confirmed by ChIP showing similar
decreases of methylated DNA in the same regions. The CIE-induced demethylation is characterized by being located near
certain transcription factor binding sequences, AP-1 and CRE, and occurred during treatment as well as after ethanol
withdrawal. Furthermore, the increase in vitro of methylated DNA decreased transcription factor binding activity and
promoter activity. An additional ChIP assay indicated that the CIE-induced DNA demethylation is accompanied by increased
occupation by transcription factors.
Conclusions: These results suggest an important role of DNA demethylation in mediating CIE-induced NR2B gene up-
regulation, thus implicating a novel molecular site of alcohol action.
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Introduction
Ethanol exposure on a chronic intermittent regimen has been
found to produce behavioral excitability, seizure susceptibility,
and increased anxiety [1,2]. Repeated alcohol-withdrawal is
known to induce long-lasting adaptations that underlie behav-
ioral phenotypes associated with alcohol addiction. Although it is
not understood mechanistically, addiction is thought to depend
on molecular and cellular adaptations that lead to persistent
changes in transcription, translation, and synaptic morphology
[3,4]. One such molecular neuroadaptation is up-regulation of
glutamate transmission, an emerging target of ethanol action in
the CNS. Glutamate is the primary excitatory neurotransmitter
in the mammalian brain, especially in all cortical pyramidal
neurons and thalamic relay neurons [5]. As a result, virtually all
thalamocortical, corticocortical and corticofugal neurotransmis-
sion is mediated by glutamate [6]. Increases in N-methyl-D-
aspartate receptor (NMDAR) subunit levels contributing to up-
regulation of glutamate transmission by ethanol exposure were
suggested by recent work showing up-regulated binding,
function, and expression following chronic ethanol treatment
[7–10]. Also, a mutation in the mouse NMDA subunit that alters
the response of the channel to ethanol implies that the NMDA
receptor is important in ethanol responses [11,12]. Perhaps
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8798increased NMDAR function, which is considered to play a
central role in the development of alcohol dependence, is at least
partly due to an increase in expression of the NR2B subunit.
Ifenprodil and eliprodil, two prototypes of NR2B subunit
selective antagonists, potently inhibit ethanol withdrawal signs
in alcohol-dependent animals [10–14]. Recent work in our
laboratory and that of others has shown that CIE induces
persistent up-regulation of NR2B gene expression and function
[15,16,17].
Epigenetic mechanisms, including DNA methylation and
histone modifications, change gene expression without alter-
ation of the DNA sequence itself. DNA methylation, as one
important epigenetic modification, was once thought to be a
static process after cellular differentiation. However, it has
recently been shown to regulate dynamically the adult nervous
system in several important phenomena [18–30], including
neurodegeneration and neuropsychiatric disorders [19,27,28],
drug addiction [20,21], plasticity and memory formation
[22,25,26,31] and activity-dependent regulation of neuronal
activity [23,29,30]. A significant example is that the exon 17
promoter of the glucocorticoid receptor in the hippocampus
undergoes active demethylation which is independent of DNA
replication as a response to maternal care after birth [24]. DNA
methylation, particularly with its stable nature, offers an ideal
mechanism to explain persistent cellular changes in neurons.
This prompted us to determine whether DNA methylation
serves as a mechanism involved in CIE-induced up-regulation
of NR2B gene expression. If so, it may represent a novel
mechanism for CIE-induced neuroadaptive regulation and,
therefore, for the development of alcoholism related behavioral
phenotypes. In the present study, we mapped for the first time
changes in methylation levels in a large number of CpG sites in
an alcohol target molecule, the NR2B gene. The result indicates
both CIE treatment and its withdrawal induced a site-specific
demethylation that in turn may lead to the up-regulation of the
NR2B gene. This finding suggests a novel molecular site of
ethanol action regarding NR2B gene transcription via an
epigenetic mechanism.
Results
5-Azacytidine (59AZA) Induced Up-Regulation of NR2B
Gene Transcription
Our previous work demonstrated a significant CIE-induced
up-regulation of NR2B gene transcription in cultured cortical
neurons [15,16]. Also an earlier study in our laboratory showed
that continuous ethanol treatment caused a few of the CpG sites
to be demethylated in the UTR in the NR2B gene [20]. We
therefore set out to determine whether DNA methylation is
involved in the CIE-induced phenomenon of NR2B gene
transcription. The structure of the 59-regulatory area of the
NR2B gene was analyzed. As shown in Figure 1A&B, a CpG
island with 116 CpG dinucleotides is located from upstream -
2000 bp (promoter) to downstream +1100 bp (59UTR) corre-
sponding to the transcription start site. This suggests that this
CpG-rich regulatory area might be potentially regulated by
DNA methylation. To investigate this, 59AZA, a DNA
methyltransferase inhibitor which can cause extensive demeth-
ylation of 5-methyl-cytosine residues, was added to neuronal
cultures at 5 mM for 48 hours. The results from real-time PCR
analysis demonstrated that 59AZA caused a significant increase
in NR2B mRNA. In contrast, there was no such effect on the
expression of the housekeepi n gg e n eG A P D H( F i g u r e2 ) .T o
confirm that 59AZA treatment indeed changes the DNA
methylation in the 59regulatory area of the NR2B gene, we
treated neuronal cultures with 59AZA for 48 hours and genomic
DNA was isolated. Bisulfite-pyrosequencing, a newly developed
sensitive and accurate method for the analysis and quantifica-
tion of the degree of DNA methylation [32], was performed to
examine methylation status in the individual CpG site. We
found that 59AZA causes an extensive demethylation (44% of
observed CpG sites) in the NR2B gene after 48 h treatment
(data not shown). This suggests that DNA methylation is
involved in the regulation of NR2B gene; based on this, we
hypothesized that the NR2B gene up-regulation caused by CIE
and 59AZA treatments may share the same mechanism, i.e.
DNA demethylation.
Figure 1. Schematic view of the 59-regulatory area of the NR2B gene. A. The structure of 59-regulatory area includes promoter (from
22000 bp to 0) and 59-UTR region (from +1t o+1100 bp) of mouse NR2B gene, containing previously identified transcription factor CREB [38] and
AP-1 [37] binding sites as indicated. B. The detailed distribution of CpG dinucleotides and their relative positions to AP-1 and CRE in 59-regulatory
area of the NR2B promoter is shown (note that the bars represent one or multi-CpG sites depending on the thickness). C. a to g represent the seven
regions chosen in this study being amplified by qChIP PCR using different primer pairs in NR2B regulatory area and relative position in 59-regulatory
area of the NR2B (for the sequences of these primers see Table S1).
doi:10.1371/journal.pone.0008798.g001
CIE Induces NR2B Demethylation
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To test this hypothesis, we investigated whether CIE treatment
results in decreased methylation by using a bisulfite-pyrosequen-
cing. Because it was unclear which CpG site may be sensitive to
ethanol, we first established a methylation profile by scanning all
116 CpG sites across the area of 3kb NR2B promoter and 59UTR.
The cultured neurons were subjected to CIE treatment, and
genomic DNA was isolated. Bisulfite conversion of genomic DNA
was performed and PCR amplification was used with at least 20
primers spanning this area. The results from pyrosequencing were
shown in Figure 3. We observed a basal pattern of methylation: a
highly methylated region from 22.0 to 21.1 kb and a low
methylated region from 21.1 to +1.1 kb. By mapping the changes
of methylation in each individual CpG with regard to the CIE
response, we found three chromatin regions with clusters of
demethylated CpG sites, two of them in the promoter (CpG sites
number 17–19 and 30–36, respectively) and one in the
downstream second intron (CpG sites number 106–116). Figure 4
shows the detailed changes in demethylation levels in each of the
15 individual CpG sites after CIE treatment and withdrawal.
Although the degree of CIE-induced demethylation varied from
10 to 100% compared to the control at these sites, there was a
significant demethylation pattern after CIE treatment and
withdrawal. Moreover, the demethylation in most of these CpG
sites persisted after ethanol removal up to at least the fifth day of
withdrawal, which is consistent with our previous finding of CIE-
induced persistent up-regulation of NR2B gene transcription
[15,16].
S-adenosyl-L-methionine (SAM) is the substrate for DNA
methyltransferases (Dnmts) in methylation reaction, which has
been previously used to rescue the hypomethylation [23]. To
provide more direct evidence that DNA methylation contributes to
CIE-induced up-regulation of NR2B gene expression, we added
SAM to the cultured neurons during CIE treatment with
expectation of blocking CIE-induced demethylation and, if this
is the case, to prevent consequent increase of the NR2B mRNA
level. The cells were harvested in the same way as that in the
regular CIE paradigm. Bisulfite conversion and pyrosequencing
were used to evaluate the methylation level; and RNA was isolated
followed by qPCR analysis. As expected, the presence of excess
SAM prevented both CIE-induced demethylation in the selected
CpG sites (Figure 4) and consequent increase of NR2B gene
mRNA compared to control (Figure 5).
Figure 2. 59AZA induced up-regulation of NR2B gene expres-
sion. The cortical neuronal cultures were treated by ethanol in CIE
regimen or 59AZA (48 hrs), respectively. Total RNA was isolated and real
time PCR for NR2B and GAPDH mRNA expression was performed.
Results are presented as the mean ratio to control 6 SEM; *, p,0.05; **,
p,0.01 compared with control levels.
doi:10.1371/journal.pone.0008798.g002
Figure 3. CIE induced DNA demethylation in the specific CpG sites determined by bisulfite-pyrosequencing. This graph outlines the
relative CpG positions, where CIE induced significantly demethylation, to the transcription start site and the binding sites of AP-1 and CREB.
Methylation status of individual CpG was determined by bisulfite-pyrosequencing at 116 CpG sites in the 59-regulatory area of the NR2B gene. All
bars represent the average basal methylation level (%) of individual CpG (control cells). The arrows in red only indicate these CpG sites where CIE
induced significant demethylation (the detailed alterations are shown in Figure 4). The locations of transcription factor AP-1 and CREB binding sites
are indicated by arrow. The bent arrow indicates the location of transcription start site.
doi:10.1371/journal.pone.0008798.g003
CIE Induces NR2B Demethylation
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we were unable to get our PCR primers to work at those sites.
Attempts to amplify these DNA sequences by PCR using several
redesigned primers and an alternative methylation specific PCR
were also not successful. However, we have used other strategies to
demonstrate the important role in these CpG sites (see results in
ChIP assay). Taken together, these data indicate that DNA
methylation in the 59regulatory region of the NR2B gene is
dynamically modified by CIE on selected site-specific CpG
dinucleotides. Thus, CIE-induced DNA demethylation may
contribute to the persistent up-regulation of NR2B gene
transcription.
CIE Decreased the Association of MeCP2 with Chromatin
in the Corresponding Regulatory Regions of the NR2B
Gene
To seek further evidence that CIE causes DNA demethylation
in the specific regions of the NR2B gene, a series of primers were
designed to amplify DNA fragments in 7 different regions (a
through g in Figure 1C) across the NR2B 59-regulatory sequences.
MeCP2, reported to be an important component of the co-
repressor complex [33–35], binds only to methylated CpG
dinucleotides [36]. Therefore, a ChIP assay was performed using
MeCP2 antibody (Abcam Inc., Cambridge) to pull down
methylated DNA fragments. To test regionally specific changes
within the 59-regulatory area, the antibody-enriched methylated
DNA was used as the template for qChIP PCR. The results show
that MeCP2-enriched DNA fragments were significantly
Figure 4. Quantitative analysis of DNA demethylation levels in the CpG sites following CIE treatment with or without SAM. Genomic
DNA isolated from control and CIE-treated cortical neuronal cultures was bisulfite-treated and pyrosequencing analyzed. The 15 individual graphs
show the detailed changes in percentage of CpG demethylation following CIE treatment and withdrawal with or without SAM in the indicated CpG
sites, which are indicated with arrows in Figure 3. The values in negative are defined in this study to represent demethylation. Results are presented
as the mean percentage of demethylation verse to the level of control (zero) 6 SEM; *, p,0.05; **, p,0.01 compared with respective control levels.
doi:10.1371/journal.pone.0008798.g004
Figure 5. SAM prevents CIE-induced up-regulation of NR2B
expression. The cortical neuronal cultures were treated by CIE
regimen with and without the presence of SAM (2 mM). Total RNA
was isolated and real time PCR for mRNA expression of NR2B was
performed. Results are presented as the mean ratio to control 6 SEM;
*, p,0.05; **, p,0.01 compared with their corresponding control levels.
doi:10.1371/journal.pone.0008798.g005
CIE Induces NR2B Demethylation
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following CIE treatment and withdrawal (Figure 6), but not in
region e (data not shown). This agrees with reduced DNA
methylation activity by CIE in the corresponding chromatin
regions, where demethylated CpG sites were identified. In
addition, it is also consistent with CIE-induced persistent
alterations in up-regulation of NR2B gene. However, the output,
NR2B gene expression is a result of the multiple mechanisms,
which reflects the complexity of the regulations. For example, the
range of changes in methylation varies among these sites, some
showing less demethylation on day 5 whereas others show more.
With respect to MeCP2 occupancy, these data indicate that about
half were at the same level at day 5 and at day 2 but others have
started to increase (recover) by Day 5 compared with that in day 2.
The Direct Role of DNA Demethylation on the
Transcription Factor Binding and Promoter Activity
Interestingly, region b and c contain transcription factors AP-1
and CREB binding sites, respectively. This suggests that CIE-
induced DNA demethylation may influence NR2B expression by
altering the binding of these transcription factors. Next, we
investigated the mechanisms involved in demethylation mediated
regulation of gene transcription by the NR2B gene promoter. The
specific binding activities of AP-1 [37] and CRE [38] sites in the
NR2B promoter have previously been identified by antibody shift
assay. In this study, these two sites were chosen to determine
whether methylation might directly interfere with transcription
factor binding and promoter activity. EMSA was performed using
synthesized oligonucleotides containing either non-methylated (C)
or methylated cytosine (C
m) within or near the transcription factor
binding sites. We observed that binding activity in the CRE site is
sensitive to DNA methylation at CpG 32. There, the presence of a
methylated CpG inside the core sequence of CRE abolished the
CREB binding. When different amounts of methylated DNA were
incorporated, the binding activity was reduced proportionately in
vitro (Figure 7A). The CIE-induced and demethylation agent,
5AZA-induced increases in transcription factors occupancy in this
sites within the NR2B promoter were also confirmed by ChIP
Assay (Figure 8). The results suggest that the methylation status of
a specific CpG site (CRE) could alter the accessibility of its
transcription factor to this site. In contrast, the binding activities of
the oligos containing two CpG flanking the AP-1 site were not
reduced by methylation in EMSA (Figure 7B). However, ChIP
array showed CIE and 59AZA induced an increased binding
activity of c-Jun, implicating the existence of indirect mechanism.
To determine whether methylation state and the corresponding
changes in CREB binding activity contribute to the functional
difference in transcription of NR2B gene, two DNA fragments in
NR2B promoter containing AP-1 and CRE sites (21.3k,+30) or
CRE site (2800,+30) only were in vitro methylated in the CpG
sites and then cloned into luciferase reporter vector (Figure 9A).
These vectors were transfected into neuronal cultures, and dual
luciferase assay was performed. The results from the in vitro
methylation assay showed that the CREB binding site was
sensitive to methylation, i.e. methylation of the fragment
containing the CRE element in the NR2B promoter reduced
promoter activities by 60%. However, and methylation had no
apparent effect on AP-1 driven promoter activity (Figure 9B).
In summary, the demethylation of NR2B gene promoter might
increased CREB binding to the promoter and activated transcrip-
tional activity of the NR2B gene. This suggests a mechanism that
mediates CIE-induced up-regulation of NR2B gene transcription.
On the other hand, the mechanism by which the AP-1 binding site
in the NR2B gene mediates ethanol effects on transcription, as
previously reported by others, may involve indirect effects of CpG
demethylation.
Figure 6. CIE reduced the association of MeCP2 with chromatin in specific regions. The chromatin fragments were prepared by cross-
linking using 1% formaldehyde and precipitating with antibody specific to MeCP2. The qChIP PCR was performed to selectively amplify the region a,
b, c, d, f and g. Each of the individual graphs represents the CIE-induced changes in region a to g (see Figure1). *, p,0.05; **, p,0.01 compared to the
control.
doi:10.1371/journal.pone.0008798.g006
CIE Induces NR2B Demethylation
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DNA methylation is catalyzed by the Dnmts [39]. Dnmt1 has
been reported as a crucial regulator in DNA methylation in the
genes responsible for the functions in brain (40–42). Therefore, it is
possible that Dnmt1 mediates CIE induces DNA demethylation.
Therefore, Dnmt1 mRNA content was examined by real time
PCR. As shown in Figure 10, CIE induced a decrease in the level
of Dnmt1 mRNA with a lasting effect.
Discussion
Recent studies have demonstrated that DNA methylation is a
dynamically regulatory process in the adult nervous system
[18–30]. An emerging concept is that the regulation of chromatin
structure through DNA methylation and histone acetylation may
mediate long-lasting changes in complicated behaviors
[21,22,29,43]. However, how methylation changes these behaviors
by altering gene expression is still unknown. NMDARs are one of
the main targets of ethanol action in the brain and, as such, have
been implicated in mediating ethanol-associated phenotypes such
as intoxication, tolerance, dependence, withdrawal, craving, and
relapse [44]. Consequently, NMDA receptors may also be critical
targets for epigenetic regulation in alcohol addiction. In this study,
we have identified a molecular target of epigenetic regulation in
alcohol addiction by focusing on the role of CIE-induced changes
in DNA methylation within the 59-regulatory area of NR2B gene.
Our data reveal three clusters of CpG dinucleotides in which CIE
treatment induced a significant decrease of DNA methylation
levels. The phenomenon of CIE-induced demethylation was
characterized by regional specificity and persistence following
ethanol removal. This provides strong support for our hypothesis
that DNA methylation mediates CIE-induced persistent up-
regulation of NR2B gene transcription. The DNA methylation
pattern is believed to be a relative balance of DNA methylation
and demethylation. To achieve the regulation to mature nervous
system, DNA methylation would also have to be an active and
reversible process to enable neurons to respond to physiological
and environmental stimuli. However, whether there is active DNA
demethylation in postmitotic cells, such as neurons, is one of
the longstanding controversies. The relevant questions also include
how the decrease of Dnmt1 results in DNA demethylation in
postmitotic neurons. There is increasing evidence recently
suggesting active methylation and demethylation regula-
tion in mediating diverse changes in the adult CNS
Figure 7. The influence of methylated CpG sites on the binding
activities of CREB and AP-1. The representatives of four indepen-
dent EMSA assays in each experiment are shown. Left: nuclear extracts
from cortical neuronal culture were incubated with end-labeled double-
stranded oligonucleotides with nonmethylated (Lane 1) and methylated
(Lane 2) CpG 32 within CRE site. Right: nuclear extracts were incubated
with probes incorporated with methylated CpG32 in 0%, 25%, 50%,
75% and 100% (Lane 3,7). 2. The probes of oligonucleotides
containing AP-1 binding site from nonmethylated (Lane 1), hemi-
methylated in sense (S, Lane 2) and anti-sense (A, Lane 3) and
methylated (Lane 4) were used in EMSA. Since we have previously
identified CREB [38] and AP-1 (family) [37] proteins binding by
antibodies shift assay, the arrows indicate CREB or AP-1 bands.
doi:10.1371/journal.pone.0008798.g007
Figure 8. 59AZA and CIE cause increased the occupancy of transcription factors with chromatin. The cultured neuronal cells were treated
by 59AZA (4 days) or CIE. The chromatin fragments were prepared by cross-linking using 1% formaldehyde and precipitating with antibodies, CREB, c-
Fos, c-Jun and FosB. The qChIP PCR was performed by using the primers amplifying the regions containing CRE and AP-1 sites, respectively. *, p,0.05
compared to the control.
doi:10.1371/journal.pone.0008798.g008
CIE Induces NR2B Demethylation
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accepted mechanisms [for review see 4,52]. There are also
reported studies showed that Dnmt1 plays a critical role in
dynamic DNA methylation and regulation of gene expression in
the adult mammalian nervous system [24,31,41,42,49]; adminis-
tration of 59AZA is able to significantly inhibit DNA methylation
in postmitotic neuronal cells or adult brain [53,54]. The present
data agree with these recent findings and add new evidence for the
active demethylation regulation in the mechanism of ethanol
addiction.
The commonly accepted mechanism of 59AZA action is based
on the initial report [55] that incorporation of cytidine analogs
into DNA in replicating cells inhibits the ability of these enzymes
to methylate DNA. However, it has been reported that
administration of 59AZA is able to significantly inhibit DNA
methylation in postmitotic neuronal cells or adult brain [53,54].
Furthermore, the idea that 59AZA inhibits methylation through a
tight covalent complex between Dnmts and 59AZA-substituted
DNA has also been challenged. DNA methyltransferase activity
decreases much faster than incorporation of 59AZA into DNA
[56]. The 59AZA-induced alteration in expression occurs inde-
pendently of the growth stage and is not due solely to the
incorporation of the analog into DNA [57]. It was also found
recently that 59-AZA-Deoxycytidine induces a proteosomal
degradation of DNMT1 that starts earlier than the incorporation
of 59AZA into DNA [58]. Thus, there are alternate mechanisms
by which 59AZA can cause demethylation other than by its
incorporation into DNA during cell division.
In the present study, we also use SAM, a methyl donor, to
specify demethylation involved in CIE-induced up-regulation of
the NR2B gene. We found that it can prevent CIE-induced up-
regulation of NR2B gene expression through blocking the
induction of demethylation. The mechanism by which SAM
increases DNA methylation has been suggested to be either by
stimulating DNA methylation enzymes [59] or by inhibiting
demethylases [60] although it need to be confirmed in the
neuronal cells.
DNA methylation results in repression of gene transcription and
loss of methylation are associated with activation of transcription
activity [61] by altering chromatin configuration and the
accessibility of transcription factor [62,63]. By focusing the affect
of methylation on transcription activity, we looked into the
relationships between the DNA methylation status of the NR2B
promoter and transcription factor accessibility as well as gene
expression. We found that two out of the three clusters of
demethylated CpG dinucleotides coincide with consensus AP-1
and CREB binding sites. These two transcription factors have
previously been identified to regulate NR2B expression in
response to chronic ethanol treatment [37,38], therefore, the
regionally specific demethylation may be critical in regulating
promoter activities mediated by AP-1 and CREB. To address
whether methylated CpG in a particular site interferes with the
binding of these transcription factors, we first examined the
interfering on binding activities of these two transcription factors
by EMSA. A methylated CpG within the CRE recognition
sequence blocked CREB binding. Conversely, loss of methylation
with the CRE recognition was associated with recovery of the
affinity binding that was proportional to methylated CpG. This
finding confirmed the direct role of DNA methylation in altering
the accessibility of transcription factors to the NR2B promoter.
This result was also confirmed by ChIP assay and qPCR. By these
analyses, we showed that 59AZA-induced demethylation was
accompanied with the increase in the interactions between CREB,
Figure 9. In vitro methylation inhibits promoter activities. A. The structure of the luciferase reporter gene constructs of the NR2B gene
promoter, containing CREB (0.8 kb) or both CREB and AP-1 (1.3 kb) binding sites. B. Constructs 1.3 and 0.8 kb were in vitro mock-methylated and
methylated and transfected into cultured cortical neurons. Cells were collected 48 h after transfection. Solid and open bars represent the luciferase
activities from mock-methylated and methylated promoter, respectively. Data (mean 6 SEM) shown are from at least three independent experiments.
*, p,0.05 compared to the mock-methylated control constructs.
doi:10.1371/journal.pone.0008798.g009
Figure 10. CIE reduced Dnmt1 expression. The cortical neuronal
cultures were treated by CIE regimen. Total RNA was isolated and real
time PCR was performed. Results are presented as the mean relative
ratio to control 6 SEM; *, p,0.05 compared with control level.
doi:10.1371/journal.pone.0008798.g010
CIE Induces NR2B Demethylation
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which is similar with CIE-induced increases of the occupancy of
the NR2B promoter with CREB and c-Jun. Furthermore, we
further investigated the functional importance of methylation
status for altering gene expression in this site by in vitro methylation
of the region surrounding this binding site. Thus, increased
methylation resulted in inhibition of promoter activity. Together,
these data show that site-specific DNA demethylation in NR2B
mediates CIE-induced up-regulation of NR2B gene transcription.
However, this may not hold true for other regions. For example,
we found no similar change in the AP-1 site as indicated by the
lack of change in transcription factor binding and promoter
activity. One possible explanation might be that AP-1 regulates
NR2B transcription through a more complicated chromatin
remodeling mechanism, e.g. histone modifications, rather than
the direct effect of demethylation in these neighboring CpG sites.
DNA methylation and histone modifications are critical epigenetic
processes controlling chromatin structure and gene regulation
[64,65]. Recent studies have suggested a complicated interaction
between them [66–68]. Thus, perhaps DNA demethylation and
histone acetylation work in concert at the AP-1 site to regulate
CIE-induced NR2B gene up-regulation. Further studies are
required to determine the precise regulation in this process.
Although we initially used MeCP2 antibody in ChIP assay to
identify methylated DNA fragment based on the earlier published
studies [33–35], we were surprise to find that CIE-induced
demethylation was accompanied by reduced occupancy of MeCP2
in the NR2B promoter and by an increase of NR2B gene
expression. We also found that knockdown of MeCP2 with
lentiviral shRNA in cultured cortical neurons results in a
significant increase of NR2B mRNA (data not shown), which is
consistent with previous reports that MeCP2 serves as a
transcriptional repressor [33–35]. However, several studies also
suggested an opposite role of MeCP2 on regulating a diversity of
genes as a transcriptional activator [69–71]. A more recent study
revealed that MeCP2 regulates the expression of a wide range of
genes in the hypothalamus as both an activator and a repressor of
transcription [71]. A possible explanation is that MeCP2-involved
regulations of gene expression might differ in specific brain regions
or type of neurons. The further study is required in addressing this
issue.
Although the mechanism of how CIE induced DNA demeth-
ylation is unknown, the role of two enzymes, Dnmts and
demethylases is the important focus. Emerging evidence suggests
the existence of demethylse [46,72], especially in postmitotic cells
[24,31,48], including the most recent study in Gadd45b mediated
activity-induced DNA demethylation in specific promoters and
gene expression for adult neurogenesis [29]. Also, the role of
Dnmt1 is implicated in the postmitotic neuronal cells, since Dnmt1
is not only highly expressed in dividing cells but is also abundant in
adult brain [40–42]. The function of Dnmt1 was commonly
accepted to be responsible for maintaining DNA methylation
patterns in the daughter strands of dividing cells and in
development of brain. So, the only way methyl groups were
thought to be lost was through passive demethylation (i.e.
replication in the absence of DNA methyltransferase) and such
processes were not considered applicable to postmitotic neurons
[73]. However, accumulating evidence has revealed that Dnmt1
plays a critical role in dynamic DNA methylation and regulation
of gene expression in the adult mammalian nervous system
[24,31,41,42,49]. For example, a recent study showed that
expression of Dnmt1 mRNA is increased in prefrontal cortical
GABAergic neurons of schizophrenia patients with decreased
GAD67 level [42]; while nicotine injections for 4 days decreased
Dnmt1 mRNA and protein with increased GAD67 expression in
the mouse frontal cortex [49]. The reduction of Dnmt1 through
shRNA or antisense oligonucleotides knockdown, as well as using
DNA methyltransferase inhibitor results DNA demethylation in
specific genes [31,50,51]. We also found that CIE-treated
neuronal cultures resulted in lasting reduction in the level of
Dnmt1, which suggests that Dnmt1 is involved in CIE-induced
NR2B demethylation although the exact mechanism needs to be
addressed in the future study.
Studies of human addiction and behavioral studies in rodent
models of addiction have indicated that key behavioral abnor-
malities associated with addiction are extremely long lived [3]. It is
particularly interesting because one critical aspect of alcohol
dependence is the lasting alterations in gene expressions during
withdrawal adaptations. Persistent up-regulation of NR2B gene
expression by chronic intermittent alcohol treatment may serve as
one mechanism underlying ethanol dependence behaviors. The
present data showed CIE-induced demethylation during a five-
day-withdrawal. Although its contribution to the ethanol related
behaviors has yet to be investigated in an animal model of alcohol
addiction, the finding in this study suggests the potential
mechanisms of epigenetic regulations in alcohol dependence.
Thereby, it might be an important focus of pharmacologic
approaches.
Materials and Methods
Cell Culture and CIE Model
Primary cortical neurons were prepared from C57BL/6 mouse
fetuses as described previously [74] with minor modifications. The
cultured cells were assigned to one of the four groups: Control (Ctl),
neurons were kept in normal medium and subjected to the media
change as other groups; CIE, neurons were exposed to 75 mM
ethanol for 5 cycles, each cycle consisting of 14 h ethanol exposure
followed by a 10 h intermittent withdrawal (neurons were harvested
in the last cycle after 14 h ethanol treatment); CIEW2, CIE plus
2 days of full withdrawal; and CIEW5, CIE plus 5 days of full
withdrawal. The ethanol-treated neuronal cultures were kept in an
incubator saturated with ethanol, which maintained the ethanol
concentration at the level added to the medium as determined by
monitoring alcohol concentration using an Analox AM1 analyzer.
During withdrawal cycles, cultures were kept in a separate ethanol-
free incubator. In view of the developmental changes during
culture, we started treatments for the different groups at different
times and harvested cells at the same age of cultured neurons (e.g.,
Ctl, no ethanol treatment; CIE, starting ethanol treatment on DIV
8; CIEW2, on DIV 6; and CIEW5, on DIV 3).
Bisulfite Conversion and Pyrosequencing
Genomic DNA (1 mg) isolated from cortical neuronal cultures
using a Blood and Cell Culture DNA kit (Qiagen), was bisulfite-
treated using the Zymo DNA Methylation Kit (Zymo research,
Orange). Bisulfite-treated DNA was eluted in 10 ml volumes with
1 ml used for each PCR. PCR was performed with primers
biotinylated to convert the PCR product to single-stranded DNA
templates. The PCR products (10 ml) were sequenced by
pyrosequencing using the PSQ96 HS System (Biotage, Kungsga-
tan, Sweden) following the manufacturer’s instructions. The
methylation status of each locus was analyzed individually as a
T/C SNP using QCpG software [75].
Real-Time PCR
Using 1 mg of total RNA as template, single-stranded cDNAs
were synthesized using random hexamers and TaqMan reverse
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the real time PCR reaction, specific probes (Applied Biosystems)
were used for NR2B expression and the SyBr green plus primers
were used for other examinations. Real-time PCR was performed
using the ABI Prism 7900 sequence detection system. The 2
2DDCt
method was used for quantification with 18s or GAPDH as
endogenous controls. Gene expression in CIE-treated cells was
expressed as fold changes by comparing to that in control cells.
Chromatin Immunoprecipitation (ChIP) Assay and
Quantitative PCR (qChIP PCR)
ChIP assays were performed as previously described [37] by
using a ChIP Express kit (Active Motif, Carlsbad). Briefly, primary
cultured cortical neurons were cross-linked with 1% formaldehyde
for 10 min at room temperature, then glycine was added to stop
the fixation, cell pellets were lysed, and nuclei were collected. The
lysed extracts were subjected to shearing by sonication. One-tenth
of the sheared DNA was kept to evaluate fragment size and DNA
concentration before immunoprecipitation and used as input. The
sizes of the majority of sonicated genomic DNA ranged from 300
to 600 bp. Equal amounts of soluble chromatin from each sample
were subjected to immunoprecipitation with different antibodies
or IgG (negative control) as indicated. The complexes were drawn
off with protein G magnetic beads and washed sequentially with
low-salt, high-salt, LiCl, and Tris-EDTA buffers. The cross-links
were reversed and followed by proteinase-K treatment. DNA
fragments were then purified with a Qiagen DNA extraction kit.
Levels of specific methylation, histone acetylation and tran-
scription factor binding in the 59regulatory area of the NR2B gene
were determined by measuring the amount of antibody enriched
chromatin DNA by quantitative real-time PCR. Primers were
designed to amplify specific regions in the 59-regulatory area of the
gene.
Controls were included to confirm specificity and validity. To
control the specificity of antibody binding, we used non-immune
rabbit IgG (Santa Cruz Biotechnology) to immunoprecipitate
chromatin samples, which resulted in negligible levels of real time
PCR activity (data not shown). For internal control of qChIP
PCR, we designed the primers to amplify GAPDH promoter (F:
59-ccaaagacagaagccaggag-39;R :5 9-catcgaacctctccccatta-39). The
levels of DNA associated with methyl-DNA binding proteins and
transcription factors at the promoter of GAPDH gene were
measured; no difference was found after CIE-treat treatment (data
not shown).
Electrophoretic Mobility Shift Assay
Nuclear extracts from cultured cortical neurons were prepared
as previously described [74]. Complementary pairs of site-specific
methylated (C
m) and non-methylated (C) oligonucleotides (Sigma-
genosys) from the regions of AP-1 and CRE in the NR2B
promoter were prepared and annealed. AP-1: 59-AGC TGG GTT
AGT CAG TGC TGT AAA ATC ATT TC(C/C
m)G TAT GGG
AAA CAT TC(C/C
m)G TTT-39. CRE: 59-CCC CAG CTC
ATG AC(C/C
m)G TGA GAA GCA GCC TCA-39. Sequences in
bold represent the core sequences of the NR2B gene promoter AP-
1 and CRE sites; two adjacent methylated CpGs near the AP-1 site
and one methylated CpG inside the CRE site are underlined. The
double-stranded oligo nucleotides were end-labeled with
[c-
32P]ATP. For reaction, 12 mg of nuclear extracts were used.
After reaction, the samples were separated by 5% non-denaturing
polyacrylamide gels, and electrophoresis was carried out. The gels
were dried subsequent to autoradiography.
In Vitro DNA Methylation and Luciferase Assay
The DNA fragments from mouse NR2B promoter regions
ranging from 21300 to +30 bp and from 2800 to +30 bp were
methylated with bacterial CpG methylase SssI or mock-methyl-
ated in vitro as described elsewhere [76]. These methylated DNA
fragments were then inserted into luciferase reporter gene vector
pGL3-Basic. Primary cultured cortical neurons grown in 24-well
plates were transfected with these vectors on DIV 5 by
lipofactamine transfection kit (Invitrogen). To control transfection
efficiency, a Renilla reniformis luciferase vector phRG (Promega) was
added per well. Cells were harvested 48 h after transfection for
luciferase activity assayed in a Turner Designs TD-20/20
luminometer using the dual luciferase assay system according to
manufacturer’s protocol (Promega).
Statistics
Two-way ANOVA followed by Newman-Keuls multiple
comparison tests were used to assess the significance of the
differences between CIE treatments and individual CpG methyl-
ation levels in bisulfite-pyrosequencing data. One-way ANOVA
followed by Newman-Keuls multiple comparison tests were used
for all other data when necessary.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0008798.s001 (0.03 MB
DOC)
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